Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.611, 2010-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dalteparin cost effective for VTE prophylaxis in the US?
Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. :
Access to resources
Recommend
Dalteparin cost effective for VTE prophylaxis in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 488, 2005-01 ,pp. :
What's the real cost of preventing chronic disease in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Lyme disease vaccine worth its cost in the US?
Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. :
The return of Tysabri to the market in the US?
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :